Fig. 3From: Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacyCorrelation of MLH1, PMS2, MSH2, and MSH6 expression in 12,821 tumor samplesBack to article page